Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| neuron | 4 studies | 24% ± 8% | |
| retinal ganglion cell | 4 studies | 50% ± 28% | |
| epithelial cell | 4 studies | 25% ± 11% | |
| GABAergic neuron | 4 studies | 38% ± 12% | |
| glutamatergic neuron | 3 studies | 48% ± 11% | |
| oligodendrocyte | 3 studies | 20% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 35% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 99% | 1361.90 | 255 / 258 | 95% | 52.36 | 219 / 230 |
| esophagus | 100% | 1706.34 | 1440 / 1445 | 92% | 24.01 | 169 / 183 |
| pancreas | 98% | 1221.01 | 323 / 328 | 93% | 21.44 | 166 / 178 |
| stomach | 98% | 1279.97 | 353 / 359 | 93% | 19.09 | 265 / 286 |
| intestine | 99% | 1610.67 | 954 / 966 | 92% | 20.59 | 486 / 527 |
| brain | 99% | 3403.78 | 2606 / 2642 | 86% | 20.36 | 605 / 705 |
| kidney | 94% | 809.35 | 84 / 89 | 86% | 19.40 | 775 / 901 |
| ovary | 100% | 2366.42 | 180 / 180 | 73% | 10.84 | 315 / 430 |
| uterus | 99% | 1505.25 | 169 / 170 | 71% | 12.93 | 324 / 459 |
| bladder | 100% | 990.33 | 21 / 21 | 61% | 9.22 | 307 / 504 |
| lung | 93% | 882.54 | 539 / 578 | 63% | 13.88 | 729 / 1155 |
| prostate | 99% | 1039.06 | 243 / 245 | 57% | 5.25 | 285 / 502 |
| skin | 98% | 1911.65 | 1770 / 1809 | 45% | 6.54 | 213 / 472 |
| thymus | 94% | 855.56 | 615 / 653 | 41% | 5.29 | 250 / 605 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.43 | 1 / 1 |
| blood vessel | 99% | 1628.26 | 1327 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 2531.25 | 824 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 21.15 | 42 / 45 |
| adipose | 86% | 664.44 | 1037 / 1204 | 0% | 0 | 0 / 0 |
| breast | 78% | 471.49 | 359 / 459 | 5% | 0.34 | 54 / 1118 |
| liver | 26% | 140.75 | 59 / 226 | 42% | 5.34 | 170 / 406 |
| muscle | 47% | 254.56 | 380 / 803 | 0% | 0 | 0 / 0 |
| spleen | 22% | 104.05 | 52 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 13% | 0.96 | 10 / 80 |
| peripheral blood | 0% | 0.86 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006506 | Biological process | GPI anchor biosynthetic process |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0016757 | Molecular function | glycosyltransferase activity |
| Gene name | PGAP4 |
| Protein name | Post-GPI attachment to proteins factor 4 (Post-GPI attachment to proteins GalNAc transferase 4) (Transmembrane protein 246) |
| Synonyms | C9orf125 TMEM246 |
| Description | FUNCTION: Golgi-resident glycosylphosphatidylinositol (GPI)-N-acetylgalactosamine transferase involved in the lipid remodeling steps of GPI-anchor maturation. Lipid remodeling steps consist in the generation of 2 saturated fatty chains at the sn-2 position of GPI-anchors proteins . Required for the initial step of GPI-GalNAc biosynthesis, transfers GalNAc to GPI in the Golgi after fatty acid remodeling by PGAP2 . . |
| Accessions | Q9BRR3 ENST00000374848.8 ENST00000374847.5 ENST00000374851.1 |
